Skip to main content

P&G stock drops to 2.5-year low

Several factors likely contributed to the recent declining value of shares despite CEO David Taylor’s revelation last week that Procter & Gamble plans to pay $4.2 billion for German firm Merck KGaA’s consumer health business, which is expected to boost P&G’s annual revenue of $65 billion by about $1.1 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.